Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kairos Pharma (KAPA) Net Cash Flow (2024 - 2025)

Kairos Pharma's Net Cash Flow history spans 2 years, with the latest figure at -$582000.0 for Q2 2025.

  • For Q2 2025, Net Cash Flow fell 2963.16% year-over-year to -$582000.0; the TTM value through Dec 2025 reached -$183000.0, down 115.52%, while the annual FY2025 figure was $3.2 million, 173.03% up from the prior year.
  • Net Cash Flow reached -$582000.0 in Q2 2025 per KAPA's latest filing, down from $2.3 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $3.2 million in Q3 2024 to a low of -$1.9 million in Q4 2024.